Related references
Note: Only part of the references are listed.Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
Thomas Treiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Controversies in the Therapy of Low-Grade Gliomas
Ivan D. Carabenciov et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Molecular genetics and therapeutic targets of pediatric low-grade gliomas
Kensuke Tateishi et al.
BRAIN TUMOR PATHOLOGY (2019)
Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications
Maryam Zare et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
Federica Di Pascale et al.
NUCLEIC ACIDS RESEARCH (2018)
miR-1193 Inhibits Glioma Cells Proliferation, Migration, and Invasion via Targeting IGF2BP2
Zupeng Chen et al.
JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING (2018)
Current and future strategies for treatment of glioma
Nancy Ann Oberheim Bush et al.
NEUROSURGICAL REVIEW (2017)
Integrated mRNAseq and microRNAseq data analysis for grade III gliomas
Junqiang Dai et al.
MOLECULAR MEDICINE REPORTS (2017)
miR-1193 Suppresses Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting IGF2BP2
Xianglei Li et al.
ONCOLOGY RESEARCH (2017)
MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility
Dengfeng Li et al.
RSC ADVANCES (2017)
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
Jun Wei et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195
Song Ye et al.
FEBS LETTERS (2016)
Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen
Xin Liu et al.
PHARMACOGENOMICS (2015)
miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
Yi Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme
Shuwei Qiu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2-IGF2BP2 Pathway
Zhizhong Li et al.
CANCER RESEARCH (2013)
MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer
Huijun Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2
Limin Long et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma
Biao Peng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
Paul Lochhead et al.
EUROPEAN JOURNAL OF CANCER (2012)
Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas
Xin Hui Derryn Chan et al.
CELL REPORTS (2012)
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs
Hongping Xia et al.
BRAIN RESEARCH (2009)
A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis
Gabriele Siegel et al.
NATURE CELL BIOLOGY (2009)
Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal
Jakub Godlewski et al.
CANCER RESEARCH (2008)
HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-κB
Isabelle Cleynen et al.
MOLECULAR CANCER RESEARCH (2007)
MicroRNA expression and function in cancer
Ramiro Garzon et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Share Paper
